Add 2 More Reports For 20% off

Report Overview

Diabetic nephropathy, also known as diabetic kidney disease, refers to a chronic deterioration of kidney function. The final stage of nephropathy is characterized by kidney failure or end-stage renal disease, with diabetes being the most common cause of end-stage renal disease. It is estimated that 30% to 40% of diabetes mellitus patients develop diabetic nephropathy.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Diabetic Nephropathy Epidemiology Forecast Report Coverage

Expert Market Research's “Diabetic Nephropathy Epidemiology Forecast Report 2024-2032” offers comprehensive information on the prevalence and demographics of diabetic nephropathy. It projects the future incidence and prevalence rates of diabetic nephropathy across various populations. The study covers age and type as major determinants of the diabetic nephropathy-affected population. The report highlights patterns in the prevalence of diabetic nephropathy over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of diabetic nephropathy in the 8 major markets.

Regions Covered

  • The United States
  • Germany
    • France
    • Italy
    • Spain
    • The United Kingdom
  • Japan
  • India

Diabetic Nephropathy: Disease Overview

Diabetic nephropathy, a common complication of type 1 and type 2 diabetes, causes the kidneys to gradually lose function. High blood sugar levels in diabetes patients often damage the blood vessels in the kidneys, subsequently leading to kidney damage. Common symptoms include swelling in the face, foamy urine, tiredness, loss of appetite, and muscle cramps, among others. There are five stages of diabetic nephropathy, with the fifth stage being end-stage renal disease (ESRD).

Diabetic Nephropathy: Treatment Overview

To slow the progression of diabetic nephropathy, lowering blood pressure and maintaining blood sugar control are extremely essential. Insulin, metformin, and SGLT2 inhibitors are the common medications that are used to control blood sugar. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin 2 receptor blockers (ARBs) are also widely prescribed for treating high blood pressure in the affected patients. Dialysis or a kidney transplant are typically the treatment options for patients whose diabetic nephropathy progresses to end-stage renal disease.

Epidemiology

The diabetic nephropathy epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for diabetic nephropathy by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for diabetic nephropathy and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

  • Research indicates that the incidence of diabetic nephropathy rises as the prevalence of diabetes increases, with around 30% to 40% of diabetes mellitus patients reported to develop diabetic nephropathy.
  • According to a research article published in the Journal of Nutrition and Metabolism (2021), 36% of people with diabetes in the United States and 25% of people with diabetes in the United Kingdom are estimated to have diabetic nephropathy.
  • As per a retrospective cohort study by Zhang, Fan et al. (2024), women carry a higher risk of developing diabetic nephropathy as well as a faster decline in renal function in comparison to men.
  • Studies show that the peak incidence (3%/year) is generally found in individuals who have had diabetes for around 10 to 20 years. Also, the mean age of diabetic patients who develop end-stage kidney disease is approximately 60 years.

Country-wise Diabetic Nephropathy Epidemiology

The diabetic nephropathy epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of diabetic nephropathy differs between countries owing to factors such as the prevalence of diabetes, genetic predisposition, lifestyle patterns, and public health policies, among others. Studies reveal that around 1 in 3 people suffering from diabetes have diabetic nephropathy as a complication in the United States.

Country Specific Stats:

Country

Prevalence (Unit)

United States

XX

United Kingdom

XX

Germany

XX

Italy

XX

France

XX

Spain

XX

Japan

XX

India

XX

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of diabetic nephropathy based on several factors.
  • Diabetic Nephropathy Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population, and the unmet needs of diabetic nephropathy are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of diabetic nephropathy epidemiology in the 8 major markets?
  • What will be the total number of patients with diabetic nephropathy across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of diabetic nephropathy in the 8 major markets in the historical period?
  • Which country will have the highest number of diabetic nephropathy patients during the forecast period of 2024-2032?
  • Which key factors would influence the shift in the patient population of diabetic nephropathy during the forecast period of 2024-2032?
  • What are the currently available treatments for diabetic nephropathy?
  • What are the disease risks, signs, symptoms, and unmet needs of diabetic nephropathy?

Related Reports

Global Diabetes Drugs Market

Type 1 Diabetes Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2023

Historical Period

2017-2023

Forecast Period

2024-2032

Geographies Covered

  • United States
  • Germany
    • Italy
    • France
    • Spain
    • United Kingdom
  • Japan
  • India

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,999

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124